The roles of the toxicologic pathologist in cancer research

Toxicologic Pathology

Volumn 38, Issue 1, 2010, Pages 39-42

  Ward, Jerrold M ^a  

^a Global VetPathology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CLASSIFICATION; CANCER RESEARCH; CANCER RISK; CARCINOGENICITY; CONFERENCE PAPER; HUMAN; MEDICAL LITERATURE; NONHUMAN; PATHOLOGIST; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; PUBLICATION; RISK ASSESSMENT; SAFETY; ANIMAL; ARTICLE; MEDICAL RESEARCH; NEOPLASM; ONCOLOGY; PATHOLOGY; PROFESSIONAL STANDARD; RAT; TOXICOLOGY; TRANSLATIONAL RESEARCH;

ANIMALIA;

ANIMALS; BIOMEDICAL RESEARCH; HUMANS; MEDICAL ONCOLOGY; NEOPLASMS; PATHOLOGY; PROFESSIONAL ROLE; RATS; RISK ASSESSMENT; TOXICOLOGY; TRANSLATIONAL RESEARCH;

EID: 77952318782     PISSN: 01926233     EISSN: 15331601     Source Type: Journal    
DOI: 10.1177/0192623309351727     Document Type: Conference Paper

References (30)

1. Adams, C. W., Allison, D. E., Flagella, K., Presta, L., Clarke, J., Dybdal, N., McKeever, K., and Sliwkowski M. X. (2006). Humanization of a recombinant monoclonal antibody to produce a therapeutic HER dimerization inhibitor, pertuzumab. Cancer Immunol Immunother 55, 717-727
2. Boorman, G. A., Eustis, S. L., Elwell, M. R., Montgomery, C. A., and MacKenzie, W. F. (Eds) (1990). Pathology of the Fischer Rat. Academic Press, San Diego, CA.
3. Boorman, G. A., Haseman, J. K., Waters, M. D., Hardisty, J. F., and Sills, R. C. (2002). Quality review procedures necessary for rodent pathology databases and toxicogenomic studies: The National Toxicology Program experience. Toxicol Pathol 30, 88-92.
4. Boyle, P., Autier, P., Bartelink, H., Baselga, J., Boffetta, P., Burn, J., Burns, H. J., Christensen, L., Denis, L., Dicato, M., Diehl, V., Doll, R., Franceschi, S., Gillis, C. R., Gray, N., Griciute, L., Hackshaw, A., Kasler, M., Kogevinas, M., Kvinnsland, S., La Vecchia, C., Levi, F., McVie, J. G., Maisonneuve, P., Martin-Moreno, J. M., Bisho, J.N., Oleari, F., Perrin, P., Quinn, M., Richards, M., Ringborg, U., Scully, C., Siracka, E., Storm, H., Tubiana, M., Tursz, T., Veronesi, U., Wald, N., Weber, W., Zaridze, D. G., Zatonski, W., and zur Hausen, H. (2003). European Code Against Cancer and scientific justification: Third version. Ann Oncol 14, 973-1005.
5. Bucher, J. R. (2002). The National Toxicology Program rodent bioassay: Designs, interpretations, and scientific contributions. Ann N Y Acad Sci 982, 198-207.
6. Cardiff, R. D., Anver, M. R., Gusterson, B. A., Hennighausen, L., Jensen, R. A., Merino, M. J., Rehm, S., Russo, J., Tavassoli, F. A., Wakefield, L. M., Ward, J. M., and Green, J. E. (2000). The mammary pathology of genetically engineered mice: The consensus report and recommendations from the Annapolis meeting. Oncogene 19, 968-988
7. Cardiff, R. D., Anver, M. R., Boivin, G. P., Bosenberg, M. W., Maronpot, R. R., Molinolo, A. A., Nikitin, A. Y., Rehg, J. E. Thomas, G. V., Russell, R. G., and Ward, J. M. (2006). Precancer in mice: animal models used to understand, prevent, and treat human precancers. Toxicol Pathol 34, 699-707.
8. Cattley, R. C. (2004). Peroxisome proliferators and receptor-mediated hepatic carcinogenesis. Toxicol Pathol 32 Suppl 2, 6-11.
9. Cohen, S. M., Klaunig, J., Meek, M. E., Hill, R. N., Pastoor, T., Lehman-McKeeman, L., Bucher, J., Longfellow, D. G., Seed, J., Dellarco, V., Fenner-Crisp, P., and Patton, D. (2004). Evaluating the human relevance of chemically induced animal tumors. Toxicol Sci 78, 181-186
10. Cohen, S. M., Ohnishi, T., Clark, N. M., He, J., and Arnold, L. L. (2007). Investigations of rodent urinary bladder carcinogens: Collection, processing, and evaluation of urine and bladders. Toxicol Pathol 35, 337-347
11. Elmore, S. (2007). Apoptosis: A review of programmed cell death. Toxicol Pathol 35, 495-516.
12. Foster, J. R. (1997). The role of cell proliferation in chemically induced carcinogenesis. J Comp Pathol 116, 113-144
13. Frame, S. R., and Mann, P. C. (2007). Principles of pathology for toxicology studies. In Principles and Methods of Toxicology, Fifth Edition, A. W. Hayes (Ed.), pp. 591-608, Informa HealthCar, New York.
14. Greaves, P. (2007). Histopathology of Preclinical Toxicity Studies, Third Edition: Interpretation and Relevance in Drug Safety Evaluation, Elsevier Science, Amsterdam.
15. Haschek,W. M.,Wallig, M. A., and Rousseaux, C. G. (2009). Fundamentals of Toxicologic Pathology, Second Edition, Academic Press. San Diego, CA.
16. Henson, D., and Albores-Saavedra, J. (2001). Pathology of Incipient Neoplasia, p. 839. Oxford University Press, Oxford, UK.
17. Holsapple, M. P., Pitot, H. C., Cohen, S. M., Boobis, A. R., Klaunig, J. E., Pastoor, T., Dellarco, V. L., and Dragan, Y. P. (2006). Mode of action in relevance of rodent liver tumors to human cancer risk. Toxicol Sci 89, 51-56.
18. Huff, J. (2002). Chemicals studied and evaluated in long-term carcinogenesis bioassays by both the Ramazzini Foundation and the National Toxicology Program: In tribute to Cesare Maltoni and David Rall. Ann N Y Acad Sci 982, 208-230
19. Kelloff, G. J., and Sigman, C. C. (2007). Assessing intraepithelial neoplasia and drug safety in cancer-preventive drug development. Nat Rev Cancer 7, 508-518
20. Kim, R., and Toge, T. (2004). Changes in therapy for solid tumors: potential for overcoming drug resistance in vivo with molecular targeting agents. Surg Today 34, 293-303.
21. Maronpot, R. R. (ed.). (1999). Pathology of the Mouse: Reference and Atlas, p. 699. Cache River Press, Vienna, IL.
22. Mohr, U. (ed.). (2001). International Classification of Rodent Tumours. The Mouse (1st ed.), p. 474. Springer Verlag, Berlin/Heidelberg, Germany.
23. Mohr, U., Dungworth, D. L., Capen, C. C., Carlton, W. W., Sundberg, J. P., and Ward J. M. (eds.) (1996). Pathobiology of the Aging Mouse, Volume 1, p. 527. ILSI Press, Washington, DC.
24. Mohr, U., Dungworth, D. L., and Capen, C. C. (Eds.) (1992). Pathobiology of the Aging Rat, vol.1. p. 485. ILSI Press, Washington, DC.
25. Nikitin, A. Yu., Alcaraz, A., Anver, M. R., Bronson, R. T., Cardiff, R. D., Dixon, D., Fraire, A. E., Gabrielson, E. W., Gunning, W. T., Haines, D. C., Kaufman, M. H., Linnoila, R. I., Maronpot, R. R., Rabson, A. S., Reddick, R. L., Rehm, S., Rozengurt, N., Schuller, H. M., Shmidt, E. N., Travis, W. D., Ward, J. M., and Jacks, T. (2004). Classification of proliferative pulmonary lesions of the mouse: Recommendations of the Mouse Models of Human Cancers Consortium. Cancer Res 64, 2307-2316
26. Olson, H., Betton, G., Robinson, D., Thomas, K., Monro, A., Kolaja, G., Lilly, P., Sanders, J., Sipes, G., Bracken, W., Dorato, M., Van Deun, K., Smith, P., Berger, B. andHeller, A. (2000). Concordance of the toxicity of pharmaceuticals in humans and in animals. Regul Toxicol Pharmacol 32, 56-67.
27. Sawyers, C. (2004). Targeted cancer therapy, Nature 432, 294-297
28. Ward, J. M., Hardisty, J. F., Hailey, J. R., and Streett, C. S. (1995). Peer review in toxicologic pathology. Toxicol Pathol 23, 226-234
29. Ward, J. M., Mahler, J. F., Maronpot, R. R., and Sundberg, J. P. (Eds.) (2000). Pathology of Genetically Engineered Mice, p. 394. Iowa State University Press, Ames, IA.
30. Ward, J. M., (2008). Value of rodent carcinogenesis bioassays. Toxicol Appl Pharmacol 226, 212.